Cochrane Abstracts
Spironolactone for hypertension
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Spironolactone for Hypertension." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433610/2/Spironolactone_for_hypertension.
Spironolactone for hypertension. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433610/2/Spironolactone_for_hypertension. Accessed January 21, 2026.
Spironolactone for hypertension. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433610/2/Spironolactone_for_hypertension
Spironolactone for Hypertension [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433610/2/Spironolactone_for_hypertension.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Spironolactone for hypertension
ID - 433610
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433610/2/Spironolactone_for_hypertension
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
